Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Tetra 2013/2014 immunogenicity and safety study in adults and elderly
2013-001094-25Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Fluarix Quadrivalent in influenza (2 arms), sponsored by GSK. Primary endpoint: Humoral immune response. Started Apr 2013; status: completed.
02
Drugs
Fluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2013-001094-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001094-25.